Related Experiment Video
Updated: Jun 3, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Clinical outcomes of management of CVAD occlusions
Calvin Peng1, Paul Monagle, Fiona Newall
1Department of Paediatrics, The University of Melbourne, Melbourne, Australia.
Abstract:
Central venous access device (CVAD) occlusions are commonly treated with tissue plasminogen activator (tPA). Eighty-seven patients with 97 catheters at The Royal Children's Hospital, Melbourne were given tPA as per clinical practice guidelines. Restoration of CVAD patency and long-term CVAD survival were measured. Cumulative CVAD restoration rates for tPA treatment were 68.5% and 78.7% after one and two doses, respectively. A significantly lower rate of successful tPA treatment was found in implantable ports (46.2% compared with 81% for Hickman catheters). CVAD time of survival until non-elective removal for 3 months, 6 months and 12 months was 64%, 57% and 47%, respectively. The authors conclude that tPA is safe and effective in extending the life of occluded CVADs occlusions by months to years but is less effective in implantable ports.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Aortic Regurgitation III: Medical Management
Acute Coronary Syndrome V: Nursing Management
Aneurysm IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Venous Thrombosis III: Interprofessional Care